Ausgabe 1/2016
Inhalt (20 Artikel)
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies
Akira I. Hida, Yasuaki Sagara, Daisuke Yotsumoto, Shuichi Kanemitsu, Junko Kawano, Shinichi Baba, Yoshiaki Rai, Yumi Oshiro, Kenjiro Aogi, Yoshiaki Sagara, Yasuyo Ohi
Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining
Rasmus Røge, Rikke Riber-Hansen, Søren Nielsen, Mogens Vyberg
Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression
Yanhong Zhang, Adam L. Liss, Eugene Chung, Lori J. Pierce, Celina G. Kleer
Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention
Justin A. Colacino, Sean P. McDermott, Maureen A. Sartor, Max S. Wicha, Laura S. Rozek
Aberrant nocturnal cortisol and disease progression in women with breast cancer
Jamie M. Zeitzer, Bita Nouriani, Michelle B. Rissling, George W. Sledge, Katherine A. Kaplan, Linn Aasly, Oxana Palesh, Booil Jo, Eric Neri, Firdaus S. Dhabhar, David Spiegel
Palbociclib as a first-line treatment in oestrogen receptor-positive, HER2-negative, advanced breast cancer not cost-effective with current pricing: a health economic analysis of the Swiss Group for Clinical Cancer Research (SAKK)
K. Matter-Walstra, T. Ruhstaller, D. Klingbiel, M. Schwenkglenks, K. J. Dedes
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients
Alexander Hein, Paul Gass, Christina Barbara Walter, Florin-Andrei Taran, Andreas Hartkopf, Friedrich Overkamp, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Johannes Ettl, Rachel Wuerstlein, Debra Lounsbury, Michael P. Lux, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Erik Belleville, Wolfgang Janni, Tanja N. Fehm, Diethelm Wallwiener, Thomas Ganslandt, Matthias Ruebner, Matthias W. Beckmann, Andreas Schneeweiss, Peter A. Fasching, Sara Y. Brucker
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer
Banu K. Arun, Yun Gong, Diane Liu, Jennifer K. Litton, Angelica M. Gutierrez-Barrera, J. Jack Lee, Lana Vornik, Nuhad K. Ibrahim, Terri Cornelison, Gabriel N. Hortobagyi, Brandy M. Heckman-Stoddard, Kimberly B. Koenig, Ricardo R. Alvarez, James L. Murray, Vicente Valero, Scott M. Lippman, Powel Brown, Nour Sneige
A randomized, double-blind, crossover trial comparing a silicone- versus water-based lubricant for sexual discomfort after breast cancer
Martha Hickey, Jennifer L. Marino, Sabine Braat, Swee Wong
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study
L. M. Smyth, N. M. Iyengar, M. F. Chen, S. M. Popper, S. Patil, C. Wasserheit-Lieblich, D. F. Argolo, J. C. Singh, S. Chandarlapaty, S. M. Sugarman, E. A. Comen, P. R. Drullinsky, T. A. Traina, T. Troso-Sandoval, J. Baselga, L. Norton, C. A. Hudis, C. T. Dang
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
Sasagu Kurozumi, Mary Padilla, Masafumi Kurosumi, Hiroshi Matsumoto, Kenichi Inoue, Jun Horiguchi, Izumi Takeyoshi, Tetsunari Oyama, Jim Ranger-Moore, D. Craig Allred, Eslie Dennis, Hiroaki Nitta
Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians
Tulay Koru-Sengul, Ana M. Santander, Feng Miao, Lidia G. Sanchez, Merce Jorda, Stefan Glück, Tan A. Ince, Mehrad Nadji, Zhibin Chen, Manuel L Penichet, Margot P. Cleary, Marta Torroella-Kouri
A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL)
Alfred I. Neugut, Grace Clarke Hillyer, Lawrence H. Kushi, Lois Lamerato, Donna L. Buono, S. David Nathanson, Dana H. Bovbjerg, Jeanne S. Mandelblatt, Wei-Yann Tsai, Judith S. Jacobson, Dawn L. Hershman
Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situ
Shi-Yi Wang, Jessica B. Long, Brigid K. Killelea, Suzanne B. Evans, Kenneth B. Roberts, Andrea Silber, Cary P. Gross
Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses’ Health Study and Nurses’ Health Study II
Kelly A. Hirko, Renée T. Fortner, Susan E. Hankinson, Tianying Wu, A. Heather Eliassen
Measured adolescent body mass index and adult breast cancer in a cohort of 951,480 women
Lital Keinan-Boker, Hagai Levine, Estela Derazne, Vered Molina-Hazan, Jeremy D. Kark
The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases
Hanna Dillekås, Romano Demicheli, Ilaria Ardoino, Svein A. H. Jensen, Elia Biganzoli, Oddbjørn Straume
Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
Shusma C. Doebar, Esther C. van den Broek, Linetta B. Koppert, Agnes Jager, Margreet. H. A. Baaijens, Inge-Marie A. M. Obdeijn, Carolien H. M. van Deurzen
Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer
Shruti R. Tiwari, Prasun Mishra, Paola Raska, Benjamin Calhoun, Jame Abraham, Halle Moore, G. Thomas Budd, Alicia Fanning, Stephanie Valente, Robyn Stewart, Stephen R. Grobmyer, Alberto J. Montero
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung
Brennan McCullar, Manjari Pandey, George Yaghmour, Felicia Hare, Kruti Patel, Matthew Stein, Rebecca Feldman, Jason C. Chandler, Michael G. Martin